儿童关节内疼痛性骨样骨瘤的CT引导射频消融:是否存在软骨损伤的担忧?
研究评估CT引导经皮射频消融治疗儿童关节内骨样骨瘤的安全性和有效性,2018年12月至2022年9月在两家三级中心治疗16例患儿,技术成功率和临床成功率均为100%,随访期间无疼痛复发,无即刻或延迟不良反应。
要点
- CT引导经皮射频消融治疗儿童关节内骨样骨瘤技术成功率和临床成功率达100%。
- 随访期间无疼痛持续或复发,无即刻或延迟不良反应。
- 作者认为该方法技术可行,可用于治疗儿童难治性关节内骨样骨瘤。
核心结论
- CT引导经皮射频消融技术可行,治疗儿童难治性关节内骨样骨瘤可获得高成功率临床改善。
研究设计与样本
- 2018年12月至2022年9月在两家三级中心治疗16例关节内骨样骨瘤患儿(男10例、女6例),采用直型单极电极在全身麻醉下行CT引导经皮射频消融,通过临床随访评估术后临床结局和不良事件。
诊断标准与关键数值
- 技术成功率100%(所有参与患者均获技术成功)。
- 临床成功率100%(随访期间症状缓解)。
- 随访期间无疼痛持续或复发。
- 无即刻或延迟不良反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the safety and efficacy of computed tomography-guided percutaneous radiofrequency ablation (PRFA) in the management of uncommon and technically challenging intra-articular osteoid osteoma in children.
MATERIAL AND METHODS: From December 2018 to September 2022, 16 children with intra-articular osteoid osteoma, including ten boys and six girls, were treated at two tertiary centers with percutaneous CT-guided RF ablation using a straight monopolar electrode. The procedures were carried out under general anesthesia. Post-procedural clinical outcomes and adverse events were assessed through clinical follow-up.
RESULTS: Technical success was achieved in all of the participating patients. Clinical success with relief of symptomatology throughout the period of follow-up was achieved in 100% of the patients. No persistence or recurrence of pain occurred during the follow-up period. No immediate or delayed adverse effects were observed.
CONCLUSION: PRFA is shown to be technically feasible. Clinical improvement can be achieved with a high rate of success in the treatment of children with difficult-to-treat intra-articular osteoid osteomas.
引用
- Balbaa, Spinelli, Arrigoni, et al. CT-guided radiofrequency ablation of painful intra-articular osteoid osteoma in children: Is there a concern for cartilage damage? Radiol Med. 2023. PMID: 37341845. doi:10.1007/s11547-023-01661-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。